Presseinformationen weltweit an Journalisten und Leser verbreiten
Liquid biopsy has transformed how we think about cancer detection, prenatal testing, and transplant monitoring. But behind every liquid biopsy result is a step that rarely gets talked about: the extraction of circulating cell-free DNA (cfDNA) from plasma. For decades, Mehr
Plant DNA extraction is notoriously demanding. Polyphenols, polysaccharides, and pigments co-purify with DNA during extraction, inhibiting downstream enzymatic reactions and reducing sequencing data quality. Silica-based methods frequently require custom buffer adaptations or result in clogged columns when processing plant tissue, Mehr
An independent performance evaluation conducted by TAmiRNA, a specialist in small RNA biomarker research, has ranked BioEcho’s EchoLUTION FFPE RNA Kit as the top-performing solution for RNA isolation from formalin-fixed paraffin-embedded (FFPE) tissue — ahead of both the silica-membrane extraction Mehr
BioEcho, an Admera Health company delivering innovative nucleic acid purification and laboratory solutions, proudly announces that it has successfully achieved ISO 9001:2015 recertification. This milestone underscores the company’s ongoing dedication to providing high-quality, reliable, and sustainable products to researchers and Mehr
For over three decades, nucleic acid purification has relied on solid-phase binding techniques. Silica membrane spin columns, once considered revolutionary, became standard. These systems force nucleic acids to bind to silica under high salt and ethanol concentrations—followed by multiple washing Mehr
BioEcho Life Sciences GmbH, ein Unternehmen von Admera Health, hat sein neues EchoLUTION™ Zellkultur-RNA-Aufreinigungs-Kit für höchste RNA-Qualität auf den Markt gebracht. Dieses Kit basiert auf der revolutionären EchoLUTION™-Technologie, womit hohe Recovery Rates und mehr verwertbare Reads in nachgelagerten Next-Generation-Sequencing Anwendungen Mehr
BioEcho Life Sciences is pleased to broadcast that the European Patent Office has granted a patent for the groundbreaking EchoLUTION technology (Nr. EP3619309). The patent application titled "Rapid purification of high-quality nucleic acids from biological samples" highlights the uniqueness and Mehr
BioEcho Life Sciences freut sich, mitteilen zu können, dass das Europäische Patentamt ein Patent für seine EchoLUTION-Technologie erteilt hat (Nr. EP3619309). Die Patentanmeldung mit dem Titel "Rapid purification of high-quality nucleic acids from biological samples" unterstreicht die Einzigartigkeit und Neuartigkeit Mehr
BioEcho Life Sciences, the biotechnology company supplying fast and sustainable nucleic acid extraction technologies, has launched its latest product: the EchoLUTION Tissue RNA Kit — designed to streamline and optimize total RNA extraction from mammalian tissues, including challenging tissues such Mehr
BioEcho Life Sciences, das Biotechnologieunternehmen, das schnelle und nachhaltige Technologien für die Nukleinsäureextraktion anbietet, hat sein neuestes Produkt auf den Markt gebracht: das EchoLUTION Tissue RNA Kit – entwickelt für optimierte Gesamt-RNA-Extraktion aus Säugetiergewebe, einschließlich schwieriger Gewebe wie Muskeln. "Wir Mehr